InvestorsHub Logo
Followers 38
Posts 2912
Boards Moderated 0
Alias Born 06/05/2012

Re: mikeslife post# 3462

Wednesday, 09/19/2018 10:51:39 AM

Wednesday, September 19, 2018 10:51:39 AM

Post# of 3840
Michael Golden has this comment at the end of the article.
“The cancer trial is being run in combination with KEYTRUDA, not Yervoy, how could you make such a major error and expect to be taken seriously?”

I believe that Providence Portland is currently running combo trials on both Keytruda and Yervoy. We are expecting the results of Cohort 3 with Keytruda shortly. I do not recall when we are expecting to hear results on Yervoy. I tried to reply to his comment but it would not let me. If you can, please reply to his comment.

"It is difficult to get a man to understand something, when his salary depends upon his not understanding it."

Upton Sinclair